HANA, Hawaii, Oct. 18, 2005 (PRIMEZONE) -- Maui General Store, Inc. (OTCBB:MAUG) announced today that it has signed a letter of intent to merge with Palmera Holdings, Inc., dba Trinity BioGenics, an emerging adult stem cell technology company. Florida-based Trinity BioGenics has distinguished itself within a growing sector of research firms that focus on the use of adult stem cell tissues to develop revolutionary medical procedures. Trinity's technological accomplishments have and will continue to contribute to a redefinition of patient treatments and therapies for chronic ailments such as heart disease, diabetes, cancer, Alzheimer's disease and Parkinson's disease.
Possessing worldwide licensing rights for the commercialization of specific uses of adult stem cells for cell therapy, Trinity also holds similar rights to the development of autologous vaccines for targeting the immune system, biological response modifiers for immune modulations, as well as novel plant extracts for biological medicines. These research frontiers are among the most sought-out by the United States Food & Drug Administration, and Trinity's current licenses have been described as five years ahead of comparable research currently under development in the United States. Recently gaining increased attention from investors due to data disclosed by researchers on September 20, that human adult stem cells helped regenerate spinal cord tissue in mice, the stem cell technology industry is poised to make great gains in the months and years ahead.
Maui General Store CEO Richard Miller commented that he is quite impressed with the technologies already developed by Trinity BioGenics: "After seeking out the best possible match of potential returns for our shareholders, we are confident that Trinity BioGenics will continue to deliver revolutionary advances in the area of biological and stem cell therapy research. In addition to the obvious potential earnings from the commercialization of this industry, it makes sense to us on a humanistic level to support the growth of medical treatments that could significantly change the quality of life as we know it."
The statements made in this press release, which are not historical facts, contain certain forward-looking statements concerning potential developments affecting the business, prospects, financial condition and other aspects of the company to which this release pertains. The actual results of the specific items described in this release, and the company's operations generally, may differ materially from what is projected in such forward-looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company's dependence on third parties, general market and economic conditions, technical factors, the availability of outside capital, receipt of revenues and other factors, many of which are beyond the control of the company. The company disclaims any obligation to update information contained in any forward-looking statement.
The Maui General Store company logo can be found at: http://www.primezone.com/newsroom/prs/?pkgid=1128